What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2020-08-14 compared with 2020-05-07 · 33 added, 35 removed, 5 unchanged (93% of the section changed)

Other Information.

The exhibits filed or furnished as part

of this Quarterly Report on Form 10-Q are set forth below.

Certification

of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of

Certification

of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of

Certification

of the Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002.

Certification

of the Principal Financial Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002.

Instance Document

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Definition Linkbase Document

XBRL Taxonomy Extension Label Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

The certifications on Exhibit 32 hereto are deemed not “filed”

for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section.

Such certifications will not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

Pursuant to the requirements of Section 13

or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned, thereunto duly authorized.

The exhibits filed

or furnished as part of this Quarterly Report on Form 10-Q are set forth below.

Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.

Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.

Certification of the Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Certification of the Principal Financial Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

XBRL Instance Document

Inline XBRL Taxonomy Extension Schema Document

Inline XBRL Taxonomy Extension Calculation Linkbase Document

Inline XBRL Taxonomy Extension Definition Linkbase Document

Inline XBRL Taxonomy Extension Label Linkbase Document

Inline XBRL Taxonomy Extension Presentation Linkbase Document

(1) The certifications on Exhibit 32 hereto are deemed not “filed” for purposes of Section

18 of the Exchange Act or otherwise subject to the liability of that Section.

Such certifications will not be deemed incorporated

by reference into any filing under the Securities Act or the Exchange Act.

Pursuant to the requirements

of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf

by the undersigned, thereunto duly authorized.

August 14, 2020

ANCHIANO THERAPEUTICS LTD.

Frank Haluska.

Chief Executive Officer

/s/ Ruth Alon

/s/ Neil Cohen

(Principal Executive Officer)

Pursuant to the requirements of Section 13

or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned, thereunto duly authorized.

Following the resignation of the Company’s Chief Executive

Frank Haluska, on July 2, 2020, the Board of Directors assumed primary responsibility for the management of the Company.

The directors whose signatures appear above are signing this document on behalf of the full Board of Directors.

Pursuant to the requirements

of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf

by the undersigned, thereunto duly authorized.

August 14, 2020

ANCHIANO THERAPEUTICS LTD.

/s/ Stephen DiPalma

Stephen DiPalma

Chief Financial Officer

/s/ Andrew Fine

Interim Chief Financial Officer

(Principal Accounting Officer and Principal Financial Officer and duly Authorized Signatory)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information